InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Browse the complete record of transactions filed by WG Biotech ApS, Director. Officer active across 1 companies, notably Y-mAbs Therapeutics, Inc.. Cumulatively, 12 reports have been logged. Total volume traded: €9.8m. The latest transaction was disclosed on 16 September 2025 (U). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations12 total
US$33m4,559,233 shares@ US$7.244387.1% of flow
Common Stock
SEC:0001753193-25-000004·
€33m4,559,233 shares@ €7.244343.5% of flow
Common Stock
SEC:0001753193-25-000004:0·
€333,51311,229 shares@ €29.70110.9% of flow
Common Stock
SEC:0001104659-21-080237·
€333,51311,229 shares@ €29.70110.4% of flow
Common Stock
SEC:0001104659-21-080237:0·
€965,01133,300 shares@ €28.97932.5% of flow
Common Stock
SEC:0001104659-21-079610·
€965,01133,300 shares@ €28.97931.3% of flow
Common Stock
SEC:0001104659-21-079610:0·
€2m72,400 shares@ €28.00785.3% of flow
Common Stock
SEC:0001104659-21-078952·
€2m72,400 shares@ €28.00782.7% of flow
Common Stock
SEC:0001104659-21-078952:0·
€838,76130,666 shares@ €27.35152.2% of flow
Common Stock
SEC:0001104659-21-077702·
€838,76130,666 shares@ €27.35151.1% of flow
Common Stock
SEC:0001104659-21-077702:0·
€745,06825,000 shares@ €29.80272.0% of flow
Common Stock
SEC:0001104659-21-075779·
€745,06825,000 shares@ €29.80271.0% of flow
Common Stock
SEC:0001104659-21-075779:0·
12 of 12 declarations
About WG Biotech ApS
WG Biotech ApS is a director at Y-mAbs Therapeutics, Inc.
